ERLOTINIB HYDROCHLORIDE | A203843 | CHARTWELL RX SCIENCES LLC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
OSI Pharmaceuticals LLC et al v. Roxane Laboratories Inc. 4 patentsANDA 203843erlotinib hydrochloride | D. Del. | 2012-12-07 | Terminated 2013-09-16 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
No patent or exclusivity listings for this strength.